Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
253.18 USD | -1.33% |
|
-1.13% | +10.63% |
06:20pm | Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing | MT |
03/07 | ResMed Founder Sells Shares Worth $250,000 | MT |
Company Valuation: ResMed, Inc.
Data adjusted to current consolidation scope
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 27,776 | 35,903 | 30,691 | 32,133 | 28,117 | 37,561 | - | - |
Change | - | 29.26% | -14.52% | 4.7% | -12.5% | 33.59% | - | - |
Enterprise Value (EV) 1 | 28,489 | 36,263 | 31,192 | 33,346 | 28,585 | 37,165 | 36,280 | 35,267 |
Change | - | 27.29% | -13.98% | 6.9% | -14.28% | 30.01% | -2.38% | -2.79% |
P/E ratio | 45x | 76.1x | 39.6x | 35.9x | 27.7x | 27.6x | 25.1x | 22.8x |
PBR | 11.1x | 12.4x | 9.35x | 7.76x | 5.78x | 6.53x | 5.56x | 4.77x |
PEG | - | -3.2x | 0.6x | 2.4x | 2x | 0.8x | 2.5x | 2.2x |
Capitalization / Revenue | 9.39x | 11.2x | 8.58x | 7.61x | 6x | 7.33x | 6.77x | 6.3x |
EV / Revenue | 9.63x | 11.3x | 8.72x | 7.9x | 6.1x | 7.25x | 6.54x | 5.92x |
EV / EBITDA | 29.5x | 33.8x | 26.8x | 25.3x | 18.1x | 19.9x | 17.7x | 15.8x |
EV / EBIT | 35.1x | 40.1x | 31.2x | 27.2x | 19.3x | 21.4x | 18.8x | 16.8x |
EV / FCF | 40.3x | 57.2x | 144x | 58.1x | 22x | 26.8x | 24.1x | 21.5x |
FCF Yield | 2.48% | 1.75% | 0.69% | 1.72% | 4.55% | 3.73% | 4.14% | 4.64% |
Dividend per Share 2 | 1.56 | 1.56 | 1.68 | 1.8 | 1.92 | 2.158 | 2.498 | 2.533 |
Rate of return | 0.81% | 0.63% | 0.8% | 0.82% | 1% | 0.84% | 0.97% | 0.99% |
EPS 2 | 4.27 | 3.24 | 5.3 | 6.09 | 6.92 | 9.288 | 10.22 | 11.27 |
Distribution rate | 36.5% | 48.1% | 31.7% | 29.6% | 27.7% | 23.2% | 24.4% | 22.5% |
Net sales 1 | 2,957 | 3,197 | 3,578 | 4,223 | 4,685 | 5,126 | 5,546 | 5,959 |
EBITDA 1 | 966 | 1,074 | 1,162 | 1,317 | 1,576 | 1,863 | 2,050 | 2,225 |
EBIT 1 | 811.2 | 903.7 | 1,000 | 1,224 | 1,478 | 1,738 | 1,927 | 2,098 |
Net income 1 | 621.7 | 474.5 | 779.4 | 897.6 | 1,021 | 1,363 | 1,507 | 1,675 |
Net Debt 1 | 713 | 360.1 | 501.5 | 1,213 | 468.9 | -395.8 | -1,281 | -2,294 |
Reference price 2 | 192.00 | 246.52 | 209.63 | 218.50 | 191.42 | 256.59 | 256.59 | 256.59 |
Nbr of stocks (in thousands) | 1,44,668 | 1,45,640 | 1,46,405 | 1,47,062 | 1,46,884 | 1,46,385 | - | - |
Announcement Date | 05/08/20 | 05/08/21 | 11/08/22 | 03/08/23 | 01/08/24 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
27.63x | 7.25x | 19.95x | 0.84% | 3.76TCr | ||
75.08x | 18.92x | 46.96x | -.--% | 19TCr | ||
24.2x | 4.22x | 16.96x | 0.39% | 16TCr | ||
53.42x | 8.16x | 27.4x | -.--% | 15TCr | ||
34.67x | 6.3x | 20.11x | 0.6% | 14TCr | ||
23.02x | 2.74x | 13.35x | 2.23% | 6.12TCr | ||
31.57x | 7.03x | 23.68x | -.--% | 4.48TCr | ||
20.85x | 6.05x | 16.19x | 3.11% | 3.66TCr | ||
18.23x | 1.95x | 11.61x | 0.18% | 3.44TCr | ||
26.72x | 5.31x | 17.8x | 0.81% | 3.44TCr | ||
Average | 33.54x | 6.79x | 21.40x | 0.82% | 8.94TCr | |
Weighted average by Cap. | 41.75x | 8.52x | 25.59x | 0.52% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- RMD Stock
- Valuation ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition